Investigación y desarrollo experimental en ciencias naturales y técnicas
Productos y servicios
Investigación de probióticos para la alimentación funcional.
Actividades
Investigación y desarrollo experimental en biotecnología
Otra investigación y desarrollo experimental en ciencias naturales y técnicas
Investigación y desarrollo experimental en biotecnología
Fabricación de otros productos básicos de química orgánica
Research and experimental development on biotechnology
Other research and experimental development on natural sciences and engineering
The company is primarily engaged in the research, development and manufacture of probiotics and specialty dietary supplements. It was incorporated in April of 2004. The company has a registered office located in Bellaterra in Barcelona, Spain. The company's team comprises professionals with expertise in different disciplines, including biotechnology, microbiology, genetics, biochemistry and chemistry, providing it with broad technical knowledge. It is a young, highly motivated team that prizes entrepreneurial spirit, scientific know-how, flexibility and success. Its team members have been hired based on academic and research excellence, as well as on their experiences in world-renowned research centers, such as Memorial Sloan-Kettering Hospital in New York, Rockefeller University in New York and the University of California, San Francisco. The company has assembled a team with excellent research planning skills to help it develop superior products. Following the 2004 spin-out of the company from the University Autònoma of Barcelona (UAB), its initial focus was on applying innovative technology to help cheese makers differentiate their products through biotechnology. This quickly expanded to other areas of microbiology, focused on developing novel probiotics and specialty dietary supplements. By investing in the development of a large, proprietary bank of wild-type bacterial strains (over 550), the company has developed a pipeline of products with novel, patentable performance characteristics. Its pipeline includes a range of proprietary supplements designed to improve health - from products that can lower the risk of cardiovascular disease to those that can help in the management of diabetes. The company's pipeline covers the development spectrum from marketed product, to proof-of-concept, and includes products that have been licensed to global food and pharmaceutical companies. To support its internal product development, it has leveraged its growing technical microbiology expertise to expand into providing contract R&D Project Management services to the nutriceutical and pharmaceutical industries. The company provides outsourced R&D solutions to pharmaceutical companies, as well as functional food companies. For the past five years, it has helped companies develop, gain financing for, and implement novel programs that are outside the focus of their internal R&D. The expertise of its R&D Partnering team includes microbiology - probiotics, including its own library of more than 500 wild type strains; neurodegenerative diseases - including novel high throughput screening methods to evaluate protein solubility of therapeutics in development; intellectual property - protecting key technologies; financing - obtaining funding for novel projects; protocol development - from literature review through protocol approval; and project execution - including close collaboration with clients to keep them apprised of progress. Its Vision: It aspires to set a standard in the European biotechnology industry for both value and profitability. Its Mission: It strives to improve health by developing products and providing services that help support healthy living and prevent disease.